Among these, the triple negative breast cancer (TNBC) is characterized by the lacking of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER2) and represents the most aggressive BC form being associated with a very poor prognosis and a high risk of mortality [3, 4]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.